SCHEMBL21724876

SCHEMBL21724876

CC(C)(C)OC(=O)N1CCc2cc(C(=O)Cl)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.46
NOTUM Q6P988 3/20 0.45
ALDH1A1 P00352 4/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
RAB9A P51151 1/20 0.44
DHODH Q02127 1/20 0.44
SRD5A1 P18405 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
ABHD6 Q9BV23 1/20 0.43
HPGD P15428 1/20 0.43
RECQL P46063 1/20 0.43
BRD4 O60885 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ESR2 Q92731 1/20 0.42
CHRM4 P08173 1/20 0.42
DRD2 P14416 1/20 0.42
HTR7 P34969 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30527088 0.88 DHODH (0.49) GPR119NOTUMALDH1A1MAPTKDM4E
SCHEMBL19689700 0.88 GPR119 (0.47) GPR119NOTUMALDH1A1MAPTKDM4E
SCHEMBL380505 0.88 DHODH (0.49) GPR119NOTUMALDH1A1MAPTKDM4E
SCHEMBL1467023 0.88 GPR119 (0.43) GPR119NOTUMALDH1A1MAPTKDM4E
SCHEMBL30681278 0.86 GPR119 (0.45) GPR119NOTUMALDH1A1MAPTKDM4E
SCHEMBL846218 0.86 HDAC1 (0.53) GPR119NOTUMALDH1A1MAPTKDM4E
SCHEMBL19689701 0.85 ALDH1A1 (0.51) GPR119ALDH1A1MAPTKDM4ERAB9A
SCHEMBL27975558 0.84 NOTUM (0.65) GPR119NOTUMDHODHABHD6ESR2
SCHEMBL3899182 0.82 ESR2 (0.61) GPR119NOTUMKDM4EDHODHABHD6
SCHEMBL8200750 0.82 NOTUM (0.64) GPR119NOTUMALDH1A1KDM4EDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572374-B2 N-cyano-7-azanorbornane derivatives and uses thereof AMGEN INC. (US) 2023-02-07 US disclosed
EP-3837262-A1 N-CYANO-7-AZANORBORNANE DERIVATIVES AND USES THEREOF Amgen Inc. (US) 2021-06-23 EP disclosed
WO-2020036940-A1 N-CYANO-7-AZANORBORNANE DERIVATIVES AND USES THEREOF AMGEN INC. (US) 2020-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572374-B2 N-cyano-7-azanorbornane derivatives and uses thereof CYP3A7, CYP51A1, NT5C3B GPR119 3448/4885NOTUM 473/4885ALDH1A1 793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.